Information Provided By:
Fly News Breaks for February 5, 2020
Feb 5, 2020 | 08:16 EDT
Oppenheimer analyst Steven Lichtman raised his price target for Zimmer Biomet to $175 from $165 after the company's Q4 beat expectations on sales and EPS. The analyst has an Outperform rating on the shares as he believes growth acceleration is on track.
News For ZBH From the Last 2 Days
There are no results for your query ZBH